Not a good buy right now for an impatient trader: the setup is bullish-but-late (price is pressing near resistance) while momentum is starting to cool (MACD histogram still >0 but contracting).
Better risk/reward would come either (1) on a clean breakout and hold above 7.94–8.12, or (2) a pullback closer to support (7.36–7.18). At 7.79, it’s in the “in-between” zone.
No supportive Intellectia signals today (no AI Stock Picker and no SwingMax), so there’s no proprietary edge to justify chasing the current level.
Technical Analysis
Trend: Bullish structure with moving averages stacked positively (SMA_5 > SMA_20 > SMA_200), indicating an uptrend is in place.
Momentum: MACD histogram is positive (0.0712) but positively contracting, suggesting upside momentum is slowing rather than accelerating.
RSI: RSI_6 at ~60 is neutral-to-slightly-bullish (not overbought), but also not a “washed-out” dip-buy reading.
Key levels: Pivot 7.647; near-term resistance R1 7.938 then R2 8.117; supports S1 7.357 then S2 7.178. Price (7.79) is closer to resistance than support.
Positioning/Sentiment (Open Interest): Put/Call OI ratio is extremely low (0.03) with call OI 2333 vs put OI 77, implying strongly call-skewed positioning.
Liquidity/Activity: Today’s options volume is 0 (calls 0, puts 0), so the sentiment read is mostly from open interest, not fresh trading.
Volatility: 30D IV is very elevated (90%) vs historical volatility (34%), with IV percentile ~86, implying the market is pricing large moves (often consistent with event proximity such as earnings).
Technical Summary
Sell
3
Buy
11
Positive Catalysts
Technical uptrend remains intact (bullish MA stack), so a breakout above ~7.94 and then ~8.12 could attract momentum buyers.
Analyst stance is constructive: Benchmark reiterated Buy and raised PT to $13 (from $12), citing confidence in continued rebound.
Pattern-based forward look provided: similar-pattern analysis suggests positive drift over the next week/month (approx. +1.72% 1-week, +3.72% 1-month).
Upcoming earnings (2026-02-18 after hours) can serve as a near-term catalyst if results/guide surprise positively.
Neutral/Negative Catalysts
while momentum is decelerating (contracting MACD histogram), increasing the chance of a stall/pullback.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $1.1125B, up +2.14% YoY (modest top-line growth).
Profitability: Net income $3.3M, down -100.76% YoY; EPS $0.02, down -100.90% YoY (sharp deterioration).
Margins: Gross margin 58.54%, up +4.20% YoY (a genuine positive operational signal, but not yet flowing through to bottom-line growth).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent rating/target trend: Benchmark (2025-11-10) maintained a Buy and raised price target to $13 from $12.
Wall Street pro view: improving operational narrative (referenced EBITDA growth) and meaningful upside implied vs current price.
Wall Street con view (based on current data): earnings power is not yet consistently improving (net income/EPS down sharply YoY), so the bull case relies on continued operational rebound translating into durable profits.
Wall Street analysts forecast LILA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LILA is 13 USD with a low forecast of 13 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast LILA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LILA is 13 USD with a low forecast of 13 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.770
Low
13
Averages
13
High
13
Current: 7.770
Low
13
Averages
13
High
13
Benchmark
Matthew Harrigan
Buy
maintain
$12 -> $13
AI Analysis
2025-11-10
Reason
Benchmark
Matthew Harrigan
Price Target
$12 -> $13
AI Analysis
2025-11-10
maintain
Buy
Reason
Benchmark analyst Matthew Harrigan raised the firm's price target on Liberty Latin America to $13 from $12 and keeps a Buy rating on the shares. The firm has "high confidence the stock should continue to rebound significantly" as it views the just reported 7% Q3 rebased EBITDA growth as indicative of sustainable performance, the analyst tells investors.
